Warning letter
Abon Biopharm (Hangzhou) Co., Ltd [ARCHIVED]: warning letter of Dec 22, 2010
FDA warning letter 151292 · Center for Devices and Radiological Health
Key facts
| Reference number | 151292 |
|---|---|
| Company | Abon Biopharm (Hangzhou) Co., Ltd [ARCHIVED] |
| Subject | CGMP/QSR/Medical Devices/Adulterated |
| Issue date | Dec 22, 2010 |
| Posted date | Dec 22, 2010 |
| Issuing office | Center for Devices and Radiological Health |
| Product type | Devices |
| CFR sections cited | 820 |
| Inspection city | Hangzhou |
| Inspection start date | Sep 19, 2010 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: